Brian Cheng's Stock Ratings

JP Morgan Analyst

Brian Cheng is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

-9.74%

Smart Score

Overall Average Return Percentile

20th

Number of Ratings

		Buy Now							Get Alert
05/02/2024	MGX	Buy Now	Metagenomi	$6.48	-7.41%	$16 → $6	Downgrade	Overweight → Neutral	Get Alert
04/30/2024	IMNM	Buy Now	Immunome	$13.90	72.66%	→ $24	Initiates	→ Overweight	Get Alert
03/22/2024	PGEN	Buy Now	Precigen	$1.38	—	—	Downgrade	Neutral → Underweight	Get Alert
Make more informed trades with Benzinga Pro You're only getting a peek at the whole story!
03/19/2024	MRSN	Buy Now	Mersana Therapeutics	$2.77	80.51%	→ $5	Upgrade	Underweight → Neutral	Get Alert
03/12/2024	ITOS	Buy Now	ITeos Therapeutics	$18.09	49.25%	$29 → $27	Maintains	Overweight	Get Alert
03/05/2024	MGX	Buy Now	Metagenomi	$6.48	146.91%	→ $16	Initiates	→ Overweight	Get Alert
03/04/2024	AHR	Buy Now	American Healthcares	$14.42	4.02%	→ $15	Initiates	→ Outperform	Get Alert
03/04/2024	KYTX	Buy Now	Kyverna Therapeutics	$14.40	170.83%	→ $39	Initiates	→ Overweight	Get Alert
02/28/2024	PTGX	Buy Now	Protagonist Therapeutics	$31.26	18.36%	$34 → $37	Maintains	Overweight	Get Alert
02/27/2024	ALLO	Buy Now	Allogene Therapeutics	$2.64	203.21%	$9 → $8	Maintains	Overweight	Get Alert
02/27/2024	EDIT	Buy Now	Editas Medicine	$5.56	61.87%	$8 → $9	Maintains	Neutral	Get Alert
02/20/2024	IMVT	Buy Now	Immunovant	$30.87	65.21%	→ $51	Initiates	→ Overweight	Get Alert
12/05/2023	CRGX	Buy Now	Cargo Therapeutics	$20.41	12.69%	→ $23	Initiates	→ Overweight	Get Alert
11/14/2023	ROIV	Buy Now	Roivant Sciences	$11.00	36.36%	$16 → $15	Maintains	Overweight	Get Alert
10/18/2023	EDIT	Buy Now	Editas Medicine	$5.56	43.88%	→ $8	Upgrade	Underweight → Neutral	Get Alert
10/12/2023	APLS	Buy Now	Apellis Pharmaceuticals	$42.50	8.24%	$44 → $46	Maintains	Neutral	Get Alert
09/25/2023	PTGX	Buy Now	Protagonist Therapeutics	$31.26	8.77%	$36 → $34	Maintains	Overweight	Get Alert
09/25/2023	BCAB	Buy Now	BioAtla	$2.47	466.8%	$17 → $14	Maintains	Overweight	Get Alert
09/25/2023	ALLO	Buy Now	Allogene Therapeutics	$2.64	241.12%	$11 → $9	Maintains	Overweight	Get Alert
09/08/2023	APLS	Buy Now	Apellis Pharmaceuticals	$42.50	1.18%	$40 → $43	Maintains	Neutral	Get Alert
08/10/2023	ADCT	Buy Now	ADC Therapeutics	$3.97	—	—	Upgrade	Underweight → Neutral	Get Alert
08/02/2023	BCAB	Buy Now	BioAtla	$2.47	588.26%	$19 → $17	Maintains	Overweight	Get Alert
08/01/2023	APLS	Buy Now	Apellis Pharmaceuticals	$42.50	-5.88%	$114 → $40	Downgrade	Buy → Neutral	Get Alert
06/16/2023	MRSN	Buy Now	Mersana Therapeutics	$2.77	80.51%	$11 → $5	Downgrade	Overweight → Neutral	Get Alert
06/01/2023	ACET	Buy Now	Adicet Bio	$1.67	259.28%	$20 → $6	Downgrade	Overweight → Neutral	Get Alert
05/23/2023	PGEN	Buy Now	Precigen	$1.38	—	—	Initiates	→ Neutral	Get Alert
05/18/2023	ROIV	Buy Now	Roivant Sciences	$11.00	27.27%	$12 → $14	Maintains	Overweight	Get Alert
04/03/2023	BCAB	Buy Now	BioAtla	$2.47	669.23%	$23 → $19	Maintains	Overweight	Get Alert
03/31/2023	NTLA	Buy Now	Intellia Therapeutics	$25.75	206.8%	$82 → $79	Maintains	Overweight	Get Alert
03/31/2023	ZYME	Buy Now	Zymeworks	$8.98	0.22%	$8 → $9	Maintains	Neutral	Get Alert